Clinical trials involves in medical research and drug development with sets of tests that produce safety and efficacy data (or more specifically, data about adverse drug reactions and antagonistic impacts of different medications) for health mediations (e.g., drugs, diagnostics, devices, therapy protocols). Clinical trials can differ in size, and can include a single research entity in one nation or many such entities in numerous nations. Clinical trials incorporates observational study, interventional study i.e. Phase 1, phase 2, phase 3 and phase 4. Presently some phase 2 and most phase 3 drug trials are composed as randomized, double-blind and placebo-controlled. In the field of rare diseases, sometimes the number of patients could be the constraining element for a clinical trial. Other clinical trials require huge numbers of participants (who may be accompanied over long periods of time), and the trial sponsor is a private company, a government health agency, or a scholastic exploration body such as a university. Journal of Blood Disorders & Transfusion is typically multidisciplinary, comprising of all fields of sciences that involve Research related to clinical trials. Various advancements in the field of clinical trials are shared among the scientists.
Last date updated on July, 2014